Delivery Order SPE2DB22D3016-SPE2DB23FBNN1
Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $12,013.11 to Amerisourcebergen Drug Corporation for 4561772065 units of the cancer drug Abraxane in 100mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 11, 2023 under the terms of the order. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, indicating this contract supports...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $57,282.72 firm fixed price delivery order contract to supply 4561431450 units of ABRAXANE 100 MG VIALS. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 10, 2023 under the terms of this order issued against an existing DLA contract vehicle. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $78,033 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of ABRAXANE, an injectable chemotherapy drug. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 16-17, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $10,412.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 100 mg vials of ABRAXANE, a chemotherapy medication used to treat breast and lung cancers. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products to DLA and various Department of Defense medical treatment facilities. Amerisourcebergen will fulfill the order from its facility located in Conshohocken,...
- The Defense Logistics Agency awarded a $8,594 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562055216 units of the cancer drug Abraxane. As the prime contractor, Amerisourcebergen will supply the 100mg vials of Abraxane to the DLA for use in its oncology programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early September 2023. The delivery order was issued under an existing DLA-wide supply...
- This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCVUA, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of 4,567,874,660 units of the pharmaceutical product ABRAXANE 100 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,382.51 and a period of performance ending on April 11, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,258.76 to AmerisourceBergen Drug Corp for 100 mg vials of Abraxane, a chemotherapy medication. This non-competitive, firm fixed-price delivery order was awarded on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Abraxane 100 mg vials, with a ceiling value of $3,781.37. The contract was competitively awarded without a set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of September 8, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for ABRAXANE 100 MG VIALS, with a ceiling value of $3,374.68 and a firm fixed price pricing type. The contract has a period of performance through May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...